Max Healthcare Institute
Max Healthcare Institute Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Max Healthcare Institute
Start SIPMax Healthcare Institute Investment Rating
-
Master Rating:
-
Max Healthcare Institute has an operating revenue of Rs. 4,283.43 Cr. on a trailing 12-month basis. An annual revenue growth of 55% is outstanding, Pre-tax margin of 19% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 62 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 482 | 474 | 427 | 381 |
| Operating Expenses Qtr Cr | 328 | 322 | 310 | 292 |
| Operating Profit Qtr Cr | 154 | 152 | 116 | 90 |
| Depreciation Qtr Cr | 28 | 28 | 24 | 24 |
| Interest Qtr Cr | 13 | 13 | 11 | 11 |
| Tax Qtr Cr | 35 | -215 | 25 | 16 |
| Net Profit Qtr Cr | 122 | 359 | 85 | 66 |
Max Healthcare Institute Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- 442.4
- 50 Day
- 440.38
- 100 Day
- 430.65
- 200 Day
- 409.53
- 20 Day
- 445.04
- 50 Day
- 441.79
- 100 Day
- 435.54
- 200 Day
- 404.7
Max Healthcare Institute Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 444.42 |
| Second Resistance | 448.59 |
| Third Resistance | 454.52 |
| RSI | 48.04 |
| MFI | 27.31 |
| MACD Single Line | -0.01 |
| MACD | -0.98 |
| Support | |
|---|---|
| First Resistance | 434.32 |
| Second Resistance | 428.39 |
| Third Resistance | 424.22 |
Max Healthcare Institute Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 987,497 | 64,197,180 | 65.01 |
| Week | 1,941,474 | 116,546,684 | 60.03 |
| 1 Month | 1,643,607 | 102,380,259 | 62.29 |
| 6 Month | 4,652,125 | 358,864,899 | 77.14 |
Max Healthcare Institute Result Highlights
Max Healthcare Institute Synopsis
NSE-Medical-Hospitals
Max Healthcare Inst. is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 1729.08 Cr. and Equity Capital is Rs. 969.61 Cr. for the Year ended 31/03/2022. Max Healthcare Institute Ltd. is a Public Limited Listed company incorporated on 18/06/2001 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L72200MH2001PLC322854 and registration number is 111313.| Market Cap | 42,703 |
| Sales | 1,764 |
| Shares in Float | 73.79 |
| No of funds | 442 |
| Yield |
| Book Value | 6.76 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | 4 |
| Alpha | 0.1 |
| Beta | 0.65 |
Max Healthcare Institute
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 23.78% | 23.8% | 50.64% | |
| Mutual Funds | 20% | 20.86% | 19.21% | |
| Insurance Companies | 0.31% | 0.13% | 0.04% | |
| Foreign Portfolio Investors | 50.15% | 49.27% | 23.34% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 4.36% | 4.54% | 4.94% | |
| Others | 1.4% | 1.4% | 1.83% |
Max Healthcare Institute Management
| Name | Designation |
|---|---|
| Mr. Abhay Soi | Chairman & Managing Director |
| Mr. Prashant Kumar | Non Exe.Non Ind.Director |
| Mr. Anil Bhatnagar | Non Exe.Non Ind.Director |
| Mr. Pranav Amin | Ind. Non-Executive Director |
| Mr. Michael Thomas Neeb | Ind. Non-Executive Director |
| Mr. Mahendra Gumanmalji Lodha | Ind. Non-Executive Director |
| Ms. Harmeen Mehta | Ind. Non-Executive Director |
| Mr. K Narasimha Murthy | Ind. Non-Executive Director |
Max Healthcare Institute Forecast
Price Estimates
Max Healthcare Institute Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-02-02 | Quarterly Results & Others | Inter alia, to consider and approve Proposal for Issue of Non-Convertible Debentures. |
| 2022-11-01 | Quarterly Results | |
| 2022-08-10 | Quarterly Results | |
| 2022-05-25 | Audited Results | |
| 2022-02-12 | Quarterly Results |
Max Healthcare Institute FAQs
What is Share Price of Max Healthcare Institute ?
Max Healthcare Institute share price is ₹438 As on 08 February, 2023 | 02:47
What is the Market Cap of Max Healthcare Institute ?
The Market Cap of Max Healthcare Institute is ₹42528.6 Cr As on 08 February, 2023 | 02:47
What is the P/E ratio of Max Healthcare Institute ?
The P/E ratio of Max Healthcare Institute is 43.6 As on 08 February, 2023 | 02:47
What is the PB ratio of Max Healthcare Institute ?
The PB ratio of Max Healthcare Institute is 6.8 As on 08 February, 2023 | 02:47